nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PLA2G2A—atherosclerosis	0.197	0.478	CbGaD
Indomethacin—PPARA—atherosclerosis	0.0843	0.204	CbGaD
Indomethacin—CXCL8—atherosclerosis	0.0584	0.142	CbGaD
Indomethacin—PPARG—atherosclerosis	0.0404	0.0979	CbGaD
Indomethacin—ABCC3—Ezetimibe—atherosclerosis	0.0235	0.0578	CbGbCtD
Indomethacin—UGT2B7—Ezetimibe—atherosclerosis	0.0203	0.05	CbGbCtD
Indomethacin—UGT2B7—Simvastatin—atherosclerosis	0.0189	0.0465	CbGbCtD
Indomethacin—UGT2B7—Lovastatin—atherosclerosis	0.0185	0.0455	CbGbCtD
Indomethacin—ABCC4—Rosuvastatin—atherosclerosis	0.018	0.0442	CbGbCtD
Indomethacin—UGT1A1—Ezetimibe—atherosclerosis	0.0176	0.0432	CbGbCtD
Indomethacin—SLC22A11—Pravastatin—atherosclerosis	0.0176	0.0432	CbGbCtD
Indomethacin—PTGS2—atherosclerosis	0.017	0.0413	CbGaD
Indomethacin—SLC22A7—Pravastatin—atherosclerosis	0.0167	0.0411	CbGbCtD
Indomethacin—UGT1A1—Simvastatin—atherosclerosis	0.0163	0.0401	CbGbCtD
Indomethacin—UGT1A1—Lovastatin—atherosclerosis	0.016	0.0393	CbGbCtD
Indomethacin—ALB—atherosclerosis	0.0152	0.0368	CbGaD
Indomethacin—ABCC1—Rosuvastatin—atherosclerosis	0.0144	0.0355	CbGbCtD
Indomethacin—SLCO1A2—Rosuvastatin—atherosclerosis	0.0129	0.0317	CbGbCtD
Indomethacin—SLCO1B1—Rosuvastatin—atherosclerosis	0.0122	0.0299	CbGbCtD
Indomethacin—SLCO1B1—Ezetimibe—atherosclerosis	0.0122	0.0299	CbGbCtD
Indomethacin—SLCO1A2—Simvastatin—atherosclerosis	0.012	0.0295	CbGbCtD
Indomethacin—SLCO1A2—Pravastatin—atherosclerosis	0.0117	0.0288	CbGbCtD
Indomethacin—SLCO1A2—Lovastatin—atherosclerosis	0.0117	0.0288	CbGbCtD
Indomethacin—SLCO1B1—Simvastatin—atherosclerosis	0.0113	0.0278	CbGbCtD
Indomethacin—SLCO1B1—Pravastatin—atherosclerosis	0.0111	0.0272	CbGbCtD
Indomethacin—SLCO1B1—Lovastatin—atherosclerosis	0.0111	0.0272	CbGbCtD
Indomethacin—ABCC2—Ezetimibe—atherosclerosis	0.0107	0.0263	CbGbCtD
Indomethacin—SLC22A8—Pravastatin—atherosclerosis	0.0102	0.0251	CbGbCtD
Indomethacin—ABCC2—Simvastatin—atherosclerosis	0.00994	0.0244	CbGbCtD
Indomethacin—ABCC2—Pravastatin—atherosclerosis	0.00973	0.0239	CbGbCtD
Indomethacin—ABCC2—Lovastatin—atherosclerosis	0.00973	0.0239	CbGbCtD
Indomethacin—SLC22A6—Pravastatin—atherosclerosis	0.00712	0.0175	CbGbCtD
Indomethacin—ALB—Rosuvastatin—atherosclerosis	0.00666	0.0164	CbGbCtD
Indomethacin—CYP2C19—Rosuvastatin—atherosclerosis	0.00432	0.0106	CbGbCtD
Indomethacin—CYP2C19—Simvastatin—atherosclerosis	0.00402	0.00987	CbGbCtD
Indomethacin—CYP2C19—Lovastatin—atherosclerosis	0.00393	0.00966	CbGbCtD
Indomethacin—CYP2C9—Rosuvastatin—atherosclerosis	0.00359	0.00883	CbGbCtD
Indomethacin—ABCB1—Ezetimibe—atherosclerosis	0.00349	0.00856	CbGbCtD
Indomethacin—CYP2C9—Simvastatin—atherosclerosis	0.00334	0.0082	CbGbCtD
Indomethacin—CYP2C9—Pravastatin—atherosclerosis	0.00327	0.00803	CbGbCtD
Indomethacin—CYP2C9—Lovastatin—atherosclerosis	0.00327	0.00803	CbGbCtD
Indomethacin—ABCB1—Simvastatin—atherosclerosis	0.00324	0.00796	CbGbCtD
Indomethacin—ABCB1—Pravastatin—atherosclerosis	0.00317	0.00779	CbGbCtD
Indomethacin—ABCB1—Lovastatin—atherosclerosis	0.00317	0.00779	CbGbCtD
Indomethacin—PPARG—leg—atherosclerosis	0.00129	0.0477	CbGeAlD
Indomethacin—PPARG—hindlimb—atherosclerosis	0.00116	0.0426	CbGeAlD
Indomethacin—PPARA—blood vessel—atherosclerosis	0.001	0.037	CbGeAlD
Indomethacin—PPARG—appendage—atherosclerosis	0.000991	0.0366	CbGeAlD
Indomethacin—PTGR2—cardiovascular system—atherosclerosis	0.000834	0.0308	CbGeAlD
Indomethacin—Fenofibrate—PPARA—atherosclerosis	0.000833	0.285	CrCbGaD
Indomethacin—PTGR2—adipose tissue—atherosclerosis	0.000736	0.0271	CbGeAlD
Indomethacin—PPARG—artery—atherosclerosis	0.000708	0.0261	CbGeAlD
Indomethacin—PTGS2—leg—atherosclerosis	0.000661	0.0244	CbGeAlD
Indomethacin—PPARG—endothelium—atherosclerosis	0.000598	0.0221	CbGeAlD
Indomethacin—PTGS2—hindlimb—atherosclerosis	0.00059	0.0218	CbGeAlD
Indomethacin—PPARG—blood vessel—atherosclerosis	0.000552	0.0204	CbGeAlD
Indomethacin—PLA2G2A—connective tissue—atherosclerosis	0.000551	0.0203	CbGeAlD
Indomethacin—ABCC6—connective tissue—atherosclerosis	0.000545	0.0201	CbGeAlD
Indomethacin—PTGR2—liver—atherosclerosis	0.000516	0.019	CbGeAlD
Indomethacin—GLO1—cardiovascular system—atherosclerosis	0.000515	0.019	CbGeAlD
Indomethacin—PPARA—connective tissue—atherosclerosis	0.000514	0.019	CbGeAlD
Indomethacin—ABCC11—liver—atherosclerosis	0.000511	0.0188	CbGeAlD
Indomethacin—PTGS2—appendage—atherosclerosis	0.000506	0.0187	CbGeAlD
Indomethacin—PLA2G2A—cardiovascular system—atherosclerosis	0.000479	0.0177	CbGeAlD
Indomethacin—ABCC6—cardiovascular system—atherosclerosis	0.000474	0.0175	CbGeAlD
Indomethacin—GLO1—adipose tissue—atherosclerosis	0.000454	0.0168	CbGeAlD
Indomethacin—PPARA—cardiovascular system—atherosclerosis	0.000448	0.0165	CbGeAlD
Indomethacin—Bezafibrate—HMGCR—atherosclerosis	0.000428	0.147	CrCbGaD
Indomethacin—PLA2G2A—adipose tissue—atherosclerosis	0.000422	0.0156	CbGeAlD
Indomethacin—Bezafibrate—PPARA—atherosclerosis	0.000421	0.144	CrCbGaD
Indomethacin—ABCC6—adipose tissue—atherosclerosis	0.000418	0.0154	CbGeAlD
Indomethacin—CXCL8—adipose tissue—atherosclerosis	0.000418	0.0154	CbGeAlD
Indomethacin—PPARA—adipose tissue—atherosclerosis	0.000395	0.0146	CbGeAlD
Indomethacin—CES1—connective tissue—atherosclerosis	0.000382	0.0141	CbGeAlD
Indomethacin—PTGS1—artery—atherosclerosis	0.000379	0.014	CbGeAlD
Indomethacin—PTGS2—artery—atherosclerosis	0.000362	0.0134	CbGeAlD
Indomethacin—Tolmetin—CXCL8—atherosclerosis	0.000355	0.122	CrCbGaD
Indomethacin—CES1—cardiovascular system—atherosclerosis	0.000332	0.0123	CbGeAlD
Indomethacin—AKR1C3—adipose tissue—atherosclerosis	0.000328	0.0121	CbGeAlD
Indomethacin—PTGS1—endothelium—atherosclerosis	0.00032	0.0118	CbGeAlD
Indomethacin—GLO1—liver—atherosclerosis	0.000319	0.0118	CbGeAlD
Indomethacin—UGT1A9—liver—atherosclerosis	0.000309	0.0114	CbGeAlD
Indomethacin—PTGS2—endothelium—atherosclerosis	0.000306	0.0113	CbGeAlD
Indomethacin—PLA2G2A—liver—atherosclerosis	0.000296	0.0109	CbGeAlD
Indomethacin—PTGS1—blood vessel—atherosclerosis	0.000295	0.0109	CbGeAlD
Indomethacin—CXCL8—liver—atherosclerosis	0.000293	0.0108	CbGeAlD
Indomethacin—ABCC6—liver—atherosclerosis	0.000293	0.0108	CbGeAlD
Indomethacin—CES1—adipose tissue—atherosclerosis	0.000293	0.0108	CbGeAlD
Indomethacin—PPARG—connective tissue—atherosclerosis	0.000283	0.0104	CbGeAlD
Indomethacin—PTGS2—blood vessel—atherosclerosis	0.000282	0.0104	CbGeAlD
Indomethacin—PPARA—liver—atherosclerosis	0.000277	0.0102	CbGeAlD
Indomethacin—Tolmetin—MPO—atherosclerosis	0.000276	0.0946	CrCbGaD
Indomethacin—SLC10A1—liver—atherosclerosis	0.000266	0.00982	CbGeAlD
Indomethacin—UGT2B7—liver—atherosclerosis	0.000249	0.0092	CbGeAlD
Indomethacin—PPARG—cardiovascular system—atherosclerosis	0.000246	0.00908	CbGeAlD
Indomethacin—SLC22A11—liver—atherosclerosis	0.000243	0.00897	CbGeAlD
Indomethacin—ABCC3—adipose tissue—atherosclerosis	0.000239	0.00881	CbGeAlD
Indomethacin—SLC22A7—liver—atherosclerosis	0.000237	0.00876	CbGeAlD
Indomethacin—AKR1C3—liver—atherosclerosis	0.00023	0.00849	CbGeAlD
Indomethacin—Flatulence—Rosuvastatin—atherosclerosis	0.000224	0.00364	CcSEcCtD
Indomethacin—Hepatitis—Lovastatin—atherosclerosis	0.000222	0.0036	CcSEcCtD
Indomethacin—Hepatitis—Ezetimibe—atherosclerosis	0.000217	0.00353	CcSEcCtD
Indomethacin—PPARG—adipose tissue—atherosclerosis	0.000217	0.00801	CbGeAlD
Indomethacin—Weight increased—Pravastatin—atherosclerosis	0.000213	0.00346	CcSEcCtD
Indomethacin—UGT1A1—liver—atherosclerosis	0.000212	0.00783	CbGeAlD
Indomethacin—Erythema multiforme—Lovastatin—atherosclerosis	0.00021	0.0034	CcSEcCtD
Indomethacin—Depression—Pravastatin—atherosclerosis	0.000208	0.00338	CcSEcCtD
Indomethacin—Angioedema—Rosuvastatin—atherosclerosis	0.000208	0.00337	CcSEcCtD
Indomethacin—Hepatitis—Simvastatin—atherosclerosis	0.000207	0.00336	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000207	0.00336	CcSEcCtD
Indomethacin—Jaundice—Niacin—atherosclerosis	0.000207	0.00335	CcSEcCtD
Indomethacin—Stomatitis—Niacin—atherosclerosis	0.000207	0.00335	CcSEcCtD
Indomethacin—Flushing—Lovastatin—atherosclerosis	0.000206	0.00334	CcSEcCtD
Indomethacin—Erythema multiforme—Ezetimibe—atherosclerosis	0.000206	0.00333	CcSEcCtD
Indomethacin—CES1—liver—atherosclerosis	0.000205	0.00758	CbGeAlD
Indomethacin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000205	0.00332	CcSEcCtD
Indomethacin—Jaundice—Pravastatin—atherosclerosis	0.000204	0.0033	CcSEcCtD
Indomethacin—Sweating—Niacin—atherosclerosis	0.000203	0.0033	CcSEcCtD
Indomethacin—Flushing—Ezetimibe—atherosclerosis	0.000202	0.00327	CcSEcCtD
Indomethacin—Bezafibrate—PPARG—atherosclerosis	0.000202	0.0691	CrCbGaD
Indomethacin—ABCC4—adipose tissue—atherosclerosis	0.000197	0.00727	CbGeAlD
Indomethacin—Erythema multiforme—Simvastatin—atherosclerosis	0.000196	0.00318	CcSEcCtD
Indomethacin—Alopecia—Lovastatin—atherosclerosis	0.000196	0.00318	CcSEcCtD
Indomethacin—Flushing—Simvastatin—atherosclerosis	0.000192	0.00312	CcSEcCtD
Indomethacin—Alopecia—Ezetimibe—atherosclerosis	0.000192	0.00312	CcSEcCtD
Indomethacin—Haemoglobin—Niacin—atherosclerosis	0.000191	0.0031	CcSEcCtD
Indomethacin—Haemorrhage—Niacin—atherosclerosis	0.00019	0.00309	CcSEcCtD
Indomethacin—Hepatitis—Niacin—atherosclerosis	0.00019	0.00309	CcSEcCtD
Indomethacin—Flatulence—Lovastatin—atherosclerosis	0.00019	0.00308	CcSEcCtD
Indomethacin—Erythema—Ezetimibe—atherosclerosis	0.000189	0.00307	CcSEcCtD
Indomethacin—Hepatitis—Pravastatin—atherosclerosis	0.000187	0.00304	CcSEcCtD
Indomethacin—Confusional state—Rosuvastatin—atherosclerosis	0.000187	0.00304	CcSEcCtD
Indomethacin—Flatulence—Ezetimibe—atherosclerosis	0.000186	0.00303	CcSEcCtD
Indomethacin—Alopecia—Simvastatin—atherosclerosis	0.000183	0.00297	CcSEcCtD
Indomethacin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000182	0.00295	CcSEcCtD
Indomethacin—Vision blurred—Lovastatin—atherosclerosis	0.000182	0.00295	CcSEcCtD
Indomethacin—Erythema—Simvastatin—atherosclerosis	0.00018	0.00293	CcSEcCtD
Indomethacin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000179	0.0029	CcSEcCtD
Indomethacin—Flatulence—Simvastatin—atherosclerosis	0.000178	0.00289	CcSEcCtD
Indomethacin—Tinnitus—Niacin—atherosclerosis	0.000177	0.00288	CcSEcCtD
Indomethacin—Erythema multiforme—Pravastatin—atherosclerosis	0.000177	0.00288	CcSEcCtD
Indomethacin—Flushing—Niacin—atherosclerosis	0.000177	0.00287	CcSEcCtD
Indomethacin—SLCO1B1—liver—atherosclerosis	0.000176	0.00651	CbGeAlD
Indomethacin—Angioedema—Lovastatin—atherosclerosis	0.000176	0.00286	CcSEcCtD
Indomethacin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000176	0.00285	CcSEcCtD
Indomethacin—Anaemia—Ezetimibe—atherosclerosis	0.000175	0.00284	CcSEcCtD
Indomethacin—Tinnitus—Pravastatin—atherosclerosis	0.000175	0.00284	CcSEcCtD
Indomethacin—ABCB1—blood vessel—atherosclerosis	0.000174	0.00644	CbGeAlD
Indomethacin—Malaise—Lovastatin—atherosclerosis	0.000174	0.00282	CcSEcCtD
Indomethacin—Flushing—Pravastatin—atherosclerosis	0.000174	0.00282	CcSEcCtD
Indomethacin—Vertigo—Lovastatin—atherosclerosis	0.000173	0.00281	CcSEcCtD
Indomethacin—Angioedema—Ezetimibe—atherosclerosis	0.000173	0.00281	CcSEcCtD
Indomethacin—Leukopenia—Lovastatin—atherosclerosis	0.000173	0.0028	CcSEcCtD
Indomethacin—Malaise—Ezetimibe—atherosclerosis	0.000171	0.00277	CcSEcCtD
Indomethacin—Vision blurred—Simvastatin—atherosclerosis	0.00017	0.00276	CcSEcCtD
Indomethacin—Arrhythmia—Niacin—atherosclerosis	0.00017	0.00276	CcSEcCtD
Indomethacin—Alopecia—Niacin—atherosclerosis	0.000168	0.00273	CcSEcCtD
Indomethacin—Insomnia—Rosuvastatin—atherosclerosis	0.000168	0.00273	CcSEcCtD
Indomethacin—ABCC1—adipose tissue—atherosclerosis	0.000168	0.0062	CbGeAlD
Indomethacin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000167	0.00272	CcSEcCtD
Indomethacin—Arrhythmia—Pravastatin—atherosclerosis	0.000167	0.00272	CcSEcCtD
Indomethacin—ABCC3—liver—atherosclerosis	0.000167	0.00618	CbGeAlD
Indomethacin—Palpitations—Ezetimibe—atherosclerosis	0.000167	0.00271	CcSEcCtD
Indomethacin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000167	0.00271	CcSEcCtD
Indomethacin—Anaemia—Simvastatin—atherosclerosis	0.000167	0.00271	CcSEcCtD
Indomethacin—Erythema—Niacin—atherosclerosis	0.000166	0.00269	CcSEcCtD
Indomethacin—Alopecia—Pravastatin—atherosclerosis	0.000166	0.00269	CcSEcCtD
Indomethacin—Angioedema—Simvastatin—atherosclerosis	0.000165	0.00268	CcSEcCtD
Indomethacin—Chest pain—Lovastatin—atherosclerosis	0.000164	0.00266	CcSEcCtD
Indomethacin—Anxiety—Lovastatin—atherosclerosis	0.000164	0.00266	CcSEcCtD
Indomethacin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000164	0.00265	CcSEcCtD
Indomethacin—Hypertension—Ezetimibe—atherosclerosis	0.000163	0.00265	CcSEcCtD
Indomethacin—Flatulence—Niacin—atherosclerosis	0.000163	0.00265	CcSEcCtD
Indomethacin—Malaise—Simvastatin—atherosclerosis	0.000163	0.00264	CcSEcCtD
Indomethacin—Tension—Niacin—atherosclerosis	0.000163	0.00264	CcSEcCtD
Indomethacin—Discomfort—Lovastatin—atherosclerosis	0.000162	0.00263	CcSEcCtD
Indomethacin—Vertigo—Simvastatin—atherosclerosis	0.000162	0.00263	CcSEcCtD
Indomethacin—Leukopenia—Simvastatin—atherosclerosis	0.000162	0.00262	CcSEcCtD
Indomethacin—Chest pain—Ezetimibe—atherosclerosis	0.000161	0.00261	CcSEcCtD
Indomethacin—Nervousness—Niacin—atherosclerosis	0.000161	0.00261	CcSEcCtD
Indomethacin—Flatulence—Pravastatin—atherosclerosis	0.000161	0.00261	CcSEcCtD
Indomethacin—Tension—Pravastatin—atherosclerosis	0.00016	0.0026	CcSEcCtD
Indomethacin—Discomfort—Ezetimibe—atherosclerosis	0.000159	0.00258	CcSEcCtD
Indomethacin—Pain—Rosuvastatin—atherosclerosis	0.000159	0.00258	CcSEcCtD
Indomethacin—Constipation—Rosuvastatin—atherosclerosis	0.000159	0.00258	CcSEcCtD
Indomethacin—Confusional state—Lovastatin—atherosclerosis	0.000159	0.00258	CcSEcCtD
Indomethacin—Nervousness—Pravastatin—atherosclerosis	0.000158	0.00257	CcSEcCtD
Indomethacin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000157	0.00255	CcSEcCtD
Indomethacin—Vision blurred—Niacin—atherosclerosis	0.000156	0.00253	CcSEcCtD
Indomethacin—Confusional state—Ezetimibe—atherosclerosis	0.000156	0.00253	CcSEcCtD
Indomethacin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000154	0.00251	CcSEcCtD
Indomethacin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000154	0.0025	CcSEcCtD
Indomethacin—Bromfenac—PTGS2—atherosclerosis	0.000154	0.0528	CrCbGaD
Indomethacin—Vision blurred—Pravastatin—atherosclerosis	0.000154	0.00249	CcSEcCtD
Indomethacin—Chest pain—Simvastatin—atherosclerosis	0.000154	0.00249	CcSEcCtD
Indomethacin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000153	0.00248	CcSEcCtD
Indomethacin—Anxiety—Simvastatin—atherosclerosis	0.000153	0.00248	CcSEcCtD
Indomethacin—PPARG—liver—atherosclerosis	0.000152	0.00562	CbGeAlD
Indomethacin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000152	0.00247	CcSEcCtD
Indomethacin—Discomfort—Simvastatin—atherosclerosis	0.000152	0.00246	CcSEcCtD
Indomethacin—Angioedema—Niacin—atherosclerosis	0.000151	0.00246	CcSEcCtD
Indomethacin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000151	0.00246	CcSEcCtD
Indomethacin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000151	0.00245	CcSEcCtD
Indomethacin—PTGS1—connective tissue—atherosclerosis	0.000151	0.00558	CbGeAlD
Indomethacin—Anaemia—Pravastatin—atherosclerosis	0.000151	0.00245	CcSEcCtD
Indomethacin—Anorexia—Lovastatin—atherosclerosis	0.00015	0.00244	CcSEcCtD
Indomethacin—Angioedema—Pravastatin—atherosclerosis	0.000149	0.00242	CcSEcCtD
Indomethacin—Vertigo—Niacin—atherosclerosis	0.000149	0.00242	CcSEcCtD
Indomethacin—Syncope—Niacin—atherosclerosis	0.000149	0.00241	CcSEcCtD
Indomethacin—Confusional state—Simvastatin—atherosclerosis	0.000149	0.00241	CcSEcCtD
Indomethacin—Leukopenia—Niacin—atherosclerosis	0.000148	0.00241	CcSEcCtD
Indomethacin—Urticaria—Rosuvastatin—atherosclerosis	0.000148	0.00239	CcSEcCtD
Indomethacin—Oedema—Simvastatin—atherosclerosis	0.000147	0.00239	CcSEcCtD
Indomethacin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000147	0.00239	CcSEcCtD
Indomethacin—Malaise—Pravastatin—atherosclerosis	0.000147	0.00239	CcSEcCtD
Indomethacin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000147	0.00238	CcSEcCtD
Indomethacin—Vertigo—Pravastatin—atherosclerosis	0.000147	0.00238	CcSEcCtD
Indomethacin—Palpitations—Niacin—atherosclerosis	0.000146	0.00238	CcSEcCtD
Indomethacin—Leukopenia—Pravastatin—atherosclerosis	0.000146	0.00237	CcSEcCtD
Indomethacin—Loss of consciousness—Niacin—atherosclerosis	0.000146	0.00236	CcSEcCtD
Indomethacin—PTGS2—connective tissue—atherosclerosis	0.000145	0.00533	CbGeAlD
Indomethacin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000144	0.00234	CcSEcCtD
Indomethacin—CYP2C9—cardiovascular system—atherosclerosis	0.000144	0.00532	CbGeAlD
Indomethacin—SLCO1A2—liver—atherosclerosis	0.000144	0.0053	CbGeAlD
Indomethacin—ALB—liver—atherosclerosis	0.000143	0.00527	CbGeAlD
Indomethacin—Insomnia—Lovastatin—atherosclerosis	0.000142	0.00231	CcSEcCtD
Indomethacin—Paraesthesia—Lovastatin—atherosclerosis	0.000141	0.00229	CcSEcCtD
Indomethacin—Hypertension—Pravastatin—atherosclerosis	0.000141	0.00229	CcSEcCtD
Indomethacin—Anorexia—Simvastatin—atherosclerosis	0.00014	0.00228	CcSEcCtD
Indomethacin—Dyspnoea—Lovastatin—atherosclerosis	0.00014	0.00228	CcSEcCtD
Indomethacin—Insomnia—Ezetimibe—atherosclerosis	0.00014	0.00227	CcSEcCtD
Indomethacin—Chest pain—Pravastatin—atherosclerosis	0.000139	0.00225	CcSEcCtD
Indomethacin—Paraesthesia—Ezetimibe—atherosclerosis	0.000139	0.00225	CcSEcCtD
Indomethacin—Dyspepsia—Lovastatin—atherosclerosis	0.000139	0.00225	CcSEcCtD
Indomethacin—Anxiety—Pravastatin—atherosclerosis	0.000138	0.00225	CcSEcCtD
Indomethacin—ABCC4—liver—atherosclerosis	0.000138	0.0051	CbGeAlD
Indomethacin—Dyspnoea—Ezetimibe—atherosclerosis	0.000138	0.00223	CcSEcCtD
Indomethacin—Discomfort—Pravastatin—atherosclerosis	0.000137	0.00223	CcSEcCtD
Indomethacin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000137	0.00222	CcSEcCtD
Indomethacin—Decreased appetite—Lovastatin—atherosclerosis	0.000137	0.00222	CcSEcCtD
Indomethacin—Dyspepsia—Ezetimibe—atherosclerosis	0.000136	0.00221	CcSEcCtD
Indomethacin—Fatigue—Lovastatin—atherosclerosis	0.000136	0.0022	CcSEcCtD
Indomethacin—Anaphylactic shock—Niacin—atherosclerosis	0.000135	0.00219	CcSEcCtD
Indomethacin—Oedema—Niacin—atherosclerosis	0.000135	0.00219	CcSEcCtD
Indomethacin—Pain—Lovastatin—atherosclerosis	0.000135	0.00218	CcSEcCtD
Indomethacin—Constipation—Lovastatin—atherosclerosis	0.000135	0.00218	CcSEcCtD
Indomethacin—Confusional state—Pravastatin—atherosclerosis	0.000134	0.00218	CcSEcCtD
Indomethacin—Decreased appetite—Ezetimibe—atherosclerosis	0.000134	0.00218	CcSEcCtD
Indomethacin—ABCC2—liver—atherosclerosis	0.000134	0.00494	CbGeAlD
Indomethacin—Asthenia—Rosuvastatin—atherosclerosis	0.000133	0.00216	CcSEcCtD
Indomethacin—Insomnia—Simvastatin—atherosclerosis	0.000133	0.00216	CcSEcCtD
Indomethacin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000133	0.00216	CcSEcCtD
Indomethacin—Oedema—Pravastatin—atherosclerosis	0.000133	0.00216	CcSEcCtD
Indomethacin—Fatigue—Ezetimibe—atherosclerosis	0.000133	0.00216	CcSEcCtD
Indomethacin—Shock—Niacin—atherosclerosis	0.000133	0.00216	CcSEcCtD
Indomethacin—Paraesthesia—Simvastatin—atherosclerosis	0.000132	0.00215	CcSEcCtD
Indomethacin—Constipation—Ezetimibe—atherosclerosis	0.000132	0.00214	CcSEcCtD
Indomethacin—Pain—Ezetimibe—atherosclerosis	0.000132	0.00214	CcSEcCtD
Indomethacin—Tachycardia—Niacin—atherosclerosis	0.000132	0.00214	CcSEcCtD
Indomethacin—PTGS1—cardiovascular system—atherosclerosis	0.000132	0.00486	CbGeAlD
Indomethacin—Pruritus—Rosuvastatin—atherosclerosis	0.000131	0.00213	CcSEcCtD
Indomethacin—Dyspnoea—Simvastatin—atherosclerosis	0.000131	0.00213	CcSEcCtD
Indomethacin—Hyperhidrosis—Niacin—atherosclerosis	0.000131	0.00212	CcSEcCtD
Indomethacin—Thrombocytopenia—Pravastatin—atherosclerosis	0.00013	0.00212	CcSEcCtD
Indomethacin—Feeling abnormal—Lovastatin—atherosclerosis	0.00013	0.00211	CcSEcCtD
Indomethacin—Dyspepsia—Simvastatin—atherosclerosis	0.00013	0.0021	CcSEcCtD
Indomethacin—Anorexia—Niacin—atherosclerosis	0.000129	0.00209	CcSEcCtD
Indomethacin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000129	0.00209	CcSEcCtD
Indomethacin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000129	0.00209	CcSEcCtD
Indomethacin—Decreased appetite—Simvastatin—atherosclerosis	0.000128	0.00208	CcSEcCtD
Indomethacin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000127	0.00206	CcSEcCtD
Indomethacin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000127	0.00206	CcSEcCtD
Indomethacin—Fatigue—Simvastatin—atherosclerosis	0.000127	0.00206	CcSEcCtD
Indomethacin—Anorexia—Pravastatin—atherosclerosis	0.000127	0.00206	CcSEcCtD
Indomethacin—Hypotension—Niacin—atherosclerosis	0.000126	0.00205	CcSEcCtD
Indomethacin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000126	0.00205	CcSEcCtD
Indomethacin—Constipation—Simvastatin—atherosclerosis	0.000126	0.00204	CcSEcCtD
Indomethacin—Pain—Simvastatin—atherosclerosis	0.000126	0.00204	CcSEcCtD
Indomethacin—PTGS2—cardiovascular system—atherosclerosis	0.000126	0.00464	CbGeAlD
Indomethacin—Urticaria—Lovastatin—atherosclerosis	0.000125	0.00203	CcSEcCtD
Indomethacin—Body temperature increased—Lovastatin—atherosclerosis	0.000124	0.00202	CcSEcCtD
Indomethacin—Abdominal pain—Lovastatin—atherosclerosis	0.000124	0.00202	CcSEcCtD
Indomethacin—Dizziness—Rosuvastatin—atherosclerosis	0.000123	0.00199	CcSEcCtD
Indomethacin—Urticaria—Ezetimibe—atherosclerosis	0.000123	0.00199	CcSEcCtD
Indomethacin—Insomnia—Niacin—atherosclerosis	0.000122	0.00198	CcSEcCtD
Indomethacin—Abdominal pain—Ezetimibe—atherosclerosis	0.000122	0.00198	CcSEcCtD
Indomethacin—Body temperature increased—Ezetimibe—atherosclerosis	0.000122	0.00198	CcSEcCtD
Indomethacin—Paraesthesia—Niacin—atherosclerosis	0.000121	0.00197	CcSEcCtD
Indomethacin—Feeling abnormal—Simvastatin—atherosclerosis	0.000121	0.00197	CcSEcCtD
Indomethacin—Dyspnoea—Niacin—atherosclerosis	0.000121	0.00196	CcSEcCtD
Indomethacin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00012	0.00195	CcSEcCtD
Indomethacin—Insomnia—Pravastatin—atherosclerosis	0.00012	0.00195	CcSEcCtD
Indomethacin—Somnolence—Niacin—atherosclerosis	0.00012	0.00195	CcSEcCtD
Indomethacin—Paraesthesia—Pravastatin—atherosclerosis	0.00012	0.00194	CcSEcCtD
Indomethacin—Dyspepsia—Niacin—atherosclerosis	0.000119	0.00193	CcSEcCtD
Indomethacin—Dyspnoea—Pravastatin—atherosclerosis	0.000119	0.00193	CcSEcCtD
Indomethacin—ABCC1—liver—atherosclerosis	0.000118	0.00435	CbGeAlD
Indomethacin—Decreased appetite—Niacin—atherosclerosis	0.000118	0.00191	CcSEcCtD
Indomethacin—Dyspepsia—Pravastatin—atherosclerosis	0.000117	0.0019	CcSEcCtD
Indomethacin—Rash—Rosuvastatin—atherosclerosis	0.000117	0.0019	CcSEcCtD
Indomethacin—Dermatitis—Rosuvastatin—atherosclerosis	0.000117	0.0019	CcSEcCtD
Indomethacin—Urticaria—Simvastatin—atherosclerosis	0.000117	0.0019	CcSEcCtD
Indomethacin—Body temperature increased—Simvastatin—atherosclerosis	0.000116	0.00189	CcSEcCtD
Indomethacin—Abdominal pain—Simvastatin—atherosclerosis	0.000116	0.00189	CcSEcCtD
Indomethacin—Headache—Rosuvastatin—atherosclerosis	0.000116	0.00189	CcSEcCtD
Indomethacin—Hypersensitivity—Lovastatin—atherosclerosis	0.000116	0.00188	CcSEcCtD
Indomethacin—PTGS1—adipose tissue—atherosclerosis	0.000116	0.00428	CbGeAlD
Indomethacin—Decreased appetite—Pravastatin—atherosclerosis	0.000116	0.00188	CcSEcCtD
Indomethacin—Pain—Niacin—atherosclerosis	0.000116	0.00188	CcSEcCtD
Indomethacin—CYP2C19—liver—atherosclerosis	0.000115	0.00424	CbGeAlD
Indomethacin—Fatigue—Pravastatin—atherosclerosis	0.000115	0.00186	CcSEcCtD
Indomethacin—Constipation—Pravastatin—atherosclerosis	0.000114	0.00185	CcSEcCtD
Indomethacin—Pain—Pravastatin—atherosclerosis	0.000114	0.00185	CcSEcCtD
Indomethacin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000114	0.00185	CcSEcCtD
Indomethacin—Asthenia—Lovastatin—atherosclerosis	0.000113	0.00183	CcSEcCtD
Indomethacin—Pruritus—Lovastatin—atherosclerosis	0.000111	0.00181	CcSEcCtD
Indomethacin—PTGS2—adipose tissue—atherosclerosis	0.000111	0.00409	CbGeAlD
Indomethacin—Asthenia—Ezetimibe—atherosclerosis	0.000111	0.0018	CcSEcCtD
Indomethacin—Gastrointestinal pain—Niacin—atherosclerosis	0.000111	0.00179	CcSEcCtD
Indomethacin—Nausea—Rosuvastatin—atherosclerosis	0.00011	0.00179	CcSEcCtD
Indomethacin—Feeling abnormal—Pravastatin—atherosclerosis	0.00011	0.00178	CcSEcCtD
Indomethacin—Pruritus—Ezetimibe—atherosclerosis	0.000109	0.00177	CcSEcCtD
Indomethacin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000109	0.00177	CcSEcCtD
Indomethacin—Hypersensitivity—Simvastatin—atherosclerosis	0.000109	0.00176	CcSEcCtD
Indomethacin—Diarrhoea—Lovastatin—atherosclerosis	0.000108	0.00175	CcSEcCtD
Indomethacin—Urticaria—Niacin—atherosclerosis	0.000107	0.00174	CcSEcCtD
Indomethacin—Body temperature increased—Niacin—atherosclerosis	0.000107	0.00173	CcSEcCtD
Indomethacin—Abdominal pain—Niacin—atherosclerosis	0.000107	0.00173	CcSEcCtD
Indomethacin—Urticaria—Pravastatin—atherosclerosis	0.000106	0.00172	CcSEcCtD
Indomethacin—Asthenia—Simvastatin—atherosclerosis	0.000106	0.00171	CcSEcCtD
Indomethacin—Diarrhoea—Ezetimibe—atherosclerosis	0.000106	0.00171	CcSEcCtD
Indomethacin—Abdominal pain—Pravastatin—atherosclerosis	0.000105	0.00171	CcSEcCtD
Indomethacin—Body temperature increased—Pravastatin—atherosclerosis	0.000105	0.00171	CcSEcCtD
Indomethacin—Pruritus—Simvastatin—atherosclerosis	0.000104	0.00169	CcSEcCtD
Indomethacin—Dizziness—Lovastatin—atherosclerosis	0.000104	0.00169	CcSEcCtD
Indomethacin—Tolmetin—PTGS2—atherosclerosis	0.000103	0.0355	CrCbGaD
Indomethacin—Dizziness—Ezetimibe—atherosclerosis	0.000102	0.00166	CcSEcCtD
Indomethacin—Diarrhoea—Simvastatin—atherosclerosis	0.000101	0.00163	CcSEcCtD
Indomethacin—Vomiting—Lovastatin—atherosclerosis	0.0001	0.00162	CcSEcCtD
Indomethacin—Hypersensitivity—Niacin—atherosclerosis	9.96e-05	0.00162	CcSEcCtD
Indomethacin—Rash—Lovastatin—atherosclerosis	9.93e-05	0.00161	CcSEcCtD
Indomethacin—Dermatitis—Lovastatin—atherosclerosis	9.92e-05	0.00161	CcSEcCtD
Indomethacin—Headache—Lovastatin—atherosclerosis	9.86e-05	0.0016	CcSEcCtD
Indomethacin—Vomiting—Ezetimibe—atherosclerosis	9.82e-05	0.00159	CcSEcCtD
Indomethacin—Hypersensitivity—Pravastatin—atherosclerosis	9.81e-05	0.00159	CcSEcCtD
Indomethacin—Dizziness—Simvastatin—atherosclerosis	9.74e-05	0.00158	CcSEcCtD
Indomethacin—Rash—Ezetimibe—atherosclerosis	9.74e-05	0.00158	CcSEcCtD
Indomethacin—Dermatitis—Ezetimibe—atherosclerosis	9.73e-05	0.00158	CcSEcCtD
Indomethacin—Asthenia—Niacin—atherosclerosis	9.7e-05	0.00157	CcSEcCtD
Indomethacin—Headache—Ezetimibe—atherosclerosis	9.68e-05	0.00157	CcSEcCtD
Indomethacin—Pruritus—Niacin—atherosclerosis	9.57e-05	0.00155	CcSEcCtD
Indomethacin—Asthenia—Pravastatin—atherosclerosis	9.55e-05	0.00155	CcSEcCtD
Indomethacin—Pruritus—Pravastatin—atherosclerosis	9.42e-05	0.00153	CcSEcCtD
Indomethacin—Vomiting—Simvastatin—atherosclerosis	9.36e-05	0.00152	CcSEcCtD
Indomethacin—Nausea—Lovastatin—atherosclerosis	9.35e-05	0.00152	CcSEcCtD
Indomethacin—Rash—Simvastatin—atherosclerosis	9.29e-05	0.00151	CcSEcCtD
Indomethacin—Dermatitis—Simvastatin—atherosclerosis	9.28e-05	0.00151	CcSEcCtD
Indomethacin—Diarrhoea—Niacin—atherosclerosis	9.25e-05	0.0015	CcSEcCtD
Indomethacin—Headache—Simvastatin—atherosclerosis	9.23e-05	0.0015	CcSEcCtD
Indomethacin—Nausea—Ezetimibe—atherosclerosis	9.17e-05	0.00149	CcSEcCtD
Indomethacin—Diarrhoea—Pravastatin—atherosclerosis	9.11e-05	0.00148	CcSEcCtD
Indomethacin—Dizziness—Niacin—atherosclerosis	8.94e-05	0.00145	CcSEcCtD
Indomethacin—CYP2C9—liver—atherosclerosis	8.91e-05	0.00329	CbGeAlD
Indomethacin—Dizziness—Pravastatin—atherosclerosis	8.81e-05	0.00143	CcSEcCtD
Indomethacin—Nausea—Simvastatin—atherosclerosis	8.75e-05	0.00142	CcSEcCtD
Indomethacin—Vomiting—Niacin—atherosclerosis	8.6e-05	0.0014	CcSEcCtD
Indomethacin—Rash—Niacin—atherosclerosis	8.53e-05	0.00138	CcSEcCtD
Indomethacin—Dermatitis—Niacin—atherosclerosis	8.52e-05	0.00138	CcSEcCtD
Indomethacin—Headache—Niacin—atherosclerosis	8.47e-05	0.00137	CcSEcCtD
Indomethacin—Vomiting—Pravastatin—atherosclerosis	8.47e-05	0.00137	CcSEcCtD
Indomethacin—Rash—Pravastatin—atherosclerosis	8.4e-05	0.00136	CcSEcCtD
Indomethacin—Dermatitis—Pravastatin—atherosclerosis	8.39e-05	0.00136	CcSEcCtD
Indomethacin—Headache—Pravastatin—atherosclerosis	8.34e-05	0.00135	CcSEcCtD
Indomethacin—Nausea—Niacin—atherosclerosis	8.03e-05	0.0013	CcSEcCtD
Indomethacin—Nausea—Pravastatin—atherosclerosis	7.91e-05	0.00128	CcSEcCtD
Indomethacin—Naproxen—PTGS2—atherosclerosis	7.79e-05	0.0267	CrCbGaD
Indomethacin—ABCB1—cardiovascular system—atherosclerosis	7.78e-05	0.00287	CbGeAlD
Indomethacin—PTGS2—liver—atherosclerosis	7.78e-05	0.00287	CbGeAlD
Indomethacin—Naproxen—ALB—atherosclerosis	6.94e-05	0.0238	CrCbGaD
Indomethacin—ABCB1—adipose tissue—atherosclerosis	6.86e-05	0.00253	CbGeAlD
Indomethacin—ABCB1—liver—atherosclerosis	4.81e-05	0.00178	CbGeAlD
Indomethacin—SLCO1B1—Metabolism—AGT—atherosclerosis	1.8e-06	2.02e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—atherosclerosis	1.8e-06	2.02e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NFKB1—atherosclerosis	1.79e-06	2.01e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NOS3—atherosclerosis	1.78e-06	2e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.78e-06	2e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CD36—atherosclerosis	1.78e-06	2e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—NOS3—atherosclerosis	1.77e-06	1.99e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—NOS3—atherosclerosis	1.77e-06	1.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—LPL—atherosclerosis	1.77e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.77e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LIPC—atherosclerosis	1.77e-06	1.99e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—atherosclerosis	1.76e-06	1.98e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—INS—atherosclerosis	1.76e-06	1.98e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK8—atherosclerosis	1.76e-06	1.98e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOC3—atherosclerosis	1.76e-06	1.97e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—atherosclerosis	1.75e-06	1.97e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CAV1—atherosclerosis	1.75e-06	1.96e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LDLR—atherosclerosis	1.75e-06	1.96e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOA1—atherosclerosis	1.74e-06	1.96e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SERPINE1—atherosclerosis	1.74e-06	1.95e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NAMPT—atherosclerosis	1.74e-06	1.95e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CG—atherosclerosis	1.74e-06	1.95e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CG—atherosclerosis	1.74e-06	1.95e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LIPC—atherosclerosis	1.73e-06	1.94e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PRKCG—atherosclerosis	1.72e-06	1.94e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMGCR—atherosclerosis	1.72e-06	1.93e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOC3—atherosclerosis	1.71e-06	1.93e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CETP—atherosclerosis	1.71e-06	1.92e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LDLR—atherosclerosis	1.7e-06	1.91e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—atherosclerosis	1.7e-06	1.91e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MTHFR—atherosclerosis	1.68e-06	1.89e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—NOS3—atherosclerosis	1.68e-06	1.88e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—atherosclerosis	1.68e-06	1.88e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—atherosclerosis	1.68e-06	1.88e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.67e-06	1.88e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.67e-06	1.88e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CETP—atherosclerosis	1.66e-06	1.87e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.66e-06	1.86e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS3—atherosclerosis	1.66e-06	1.86e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARA—atherosclerosis	1.65e-06	1.86e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—INS—atherosclerosis	1.64e-06	1.85e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—INS—atherosclerosis	1.64e-06	1.85e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.63e-06	1.84e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.63e-06	1.83e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—atherosclerosis	1.63e-06	1.83e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—HMOX1—atherosclerosis	1.62e-06	1.82e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—atherosclerosis	1.62e-06	1.82e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—atherosclerosis	1.62e-06	1.82e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.62e-06	1.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—atherosclerosis	1.62e-06	1.81e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—atherosclerosis	1.61e-06	1.81e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.61e-06	1.81e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LIPC—atherosclerosis	1.61e-06	1.81e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—atherosclerosis	1.61e-06	1.81e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—atherosclerosis	1.61e-06	1.8e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOC3—atherosclerosis	1.6e-06	1.8e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AGT—atherosclerosis	1.6e-06	1.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTHFR—atherosclerosis	1.6e-06	1.79e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SCARB1—atherosclerosis	1.59e-06	1.79e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LDLR—atherosclerosis	1.59e-06	1.79e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	1.59e-06	1.79e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.59e-06	1.79e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—INS—atherosclerosis	1.58e-06	1.78e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—atherosclerosis	1.57e-06	1.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOB—atherosclerosis	1.56e-06	1.75e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CETP—atherosclerosis	1.56e-06	1.75e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PDGFB—atherosclerosis	1.55e-06	1.75e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CAV1—atherosclerosis	1.55e-06	1.75e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOA1—atherosclerosis	1.55e-06	1.74e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.55e-06	1.74e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—atherosclerosis	1.54e-06	1.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.54e-06	1.73e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK3—atherosclerosis	1.54e-06	1.73e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—atherosclerosis	1.54e-06	1.72e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—atherosclerosis	1.53e-06	1.72e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCA1—atherosclerosis	1.53e-06	1.72e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—atherosclerosis	1.53e-06	1.71e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—atherosclerosis	1.52e-06	1.7e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTM1—atherosclerosis	1.51e-06	1.7e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—atherosclerosis	1.51e-06	1.69e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—atherosclerosis	1.51e-06	1.69e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—INS—atherosclerosis	1.51e-06	1.69e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMGCR—atherosclerosis	1.51e-06	1.69e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—atherosclerosis	1.5e-06	1.69e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—atherosclerosis	1.49e-06	1.68e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.49e-06	1.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—atherosclerosis	1.49e-06	1.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—LPL—atherosclerosis	1.49e-06	1.67e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—atherosclerosis	1.48e-06	1.66e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.48e-06	1.66e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CAV1—atherosclerosis	1.47e-06	1.65e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MAPK3—atherosclerosis	1.47e-06	1.65e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOA1—atherosclerosis	1.47e-06	1.65e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—atherosclerosis	1.45e-06	1.63e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.45e-06	1.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX1—atherosclerosis	1.45e-06	1.63e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—atherosclerosis	1.44e-06	1.62e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—atherosclerosis	1.44e-06	1.62e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—atherosclerosis	1.44e-06	1.62e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—atherosclerosis	1.43e-06	1.6e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.42e-06	1.59e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NFKB1—atherosclerosis	1.41e-06	1.59e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—atherosclerosis	1.41e-06	1.59e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CD36—atherosclerosis	1.41e-06	1.59e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.41e-06	1.58e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.39e-06	1.56e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—atherosclerosis	1.39e-06	1.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK8—atherosclerosis	1.39e-06	1.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—atherosclerosis	1.39e-06	1.56e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—atherosclerosis	1.39e-06	1.56e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—atherosclerosis	1.38e-06	1.55e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—atherosclerosis	1.38e-06	1.55e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.37e-06	1.54e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—atherosclerosis	1.37e-06	1.53e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ABCA1—atherosclerosis	1.34e-06	1.51e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—atherosclerosis	1.34e-06	1.51e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—INS—atherosclerosis	1.34e-06	1.5e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—atherosclerosis	1.34e-06	1.5e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—atherosclerosis	1.32e-06	1.48e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—atherosclerosis	1.32e-06	1.48e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—atherosclerosis	1.32e-06	1.48e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMOX1—atherosclerosis	1.31e-06	1.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARA—atherosclerosis	1.31e-06	1.47e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—atherosclerosis	1.28e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—atherosclerosis	1.27e-06	1.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AGT—atherosclerosis	1.27e-06	1.43e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—atherosclerosis	1.27e-06	1.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—INS—atherosclerosis	1.27e-06	1.43e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.27e-06	1.42e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—atherosclerosis	1.27e-06	1.42e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOB—atherosclerosis	1.26e-06	1.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.25e-06	1.41e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—atherosclerosis	1.25e-06	1.4e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—atherosclerosis	1.24e-06	1.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAV1—atherosclerosis	1.23e-06	1.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOA1—atherosclerosis	1.23e-06	1.38e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—atherosclerosis	1.23e-06	1.38e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—atherosclerosis	1.23e-06	1.38e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—atherosclerosis	1.22e-06	1.38e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—atherosclerosis	1.21e-06	1.36e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—atherosclerosis	1.21e-06	1.36e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—LPL—atherosclerosis	1.2e-06	1.35e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—atherosclerosis	1.18e-06	1.33e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.18e-06	1.32e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—atherosclerosis	1.18e-06	1.32e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—atherosclerosis	1.18e-06	1.32e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—atherosclerosis	1.17e-06	1.32e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—atherosclerosis	1.17e-06	1.31e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMOX1—atherosclerosis	1.15e-06	1.29e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CD36—atherosclerosis	1.14e-06	1.28e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—atherosclerosis	1.13e-06	1.27e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOB—atherosclerosis	1.13e-06	1.27e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—atherosclerosis	1.12e-06	1.26e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.12e-06	1.26e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—atherosclerosis	1.11e-06	1.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOB—atherosclerosis	1.1e-06	1.24e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.1e-06	1.23e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—atherosclerosis	1.1e-06	1.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—atherosclerosis	1.08e-06	1.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—atherosclerosis	1.08e-06	1.22e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LPL—atherosclerosis	1.08e-06	1.21e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—atherosclerosis	1.08e-06	1.21e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.08e-06	1.21e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—atherosclerosis	1.07e-06	1.21e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—atherosclerosis	1.07e-06	1.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—INS—atherosclerosis	1.06e-06	1.19e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARA—atherosclerosis	1.06e-06	1.19e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LPL—atherosclerosis	1.05e-06	1.18e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—atherosclerosis	1.05e-06	1.18e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—atherosclerosis	1.04e-06	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOB—atherosclerosis	1.03e-06	1.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AGT—atherosclerosis	1.03e-06	1.15e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—atherosclerosis	1.03e-06	1.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD36—atherosclerosis	1.03e-06	1.15e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—atherosclerosis	1.01e-06	1.13e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—atherosclerosis	1e-06	1.13e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD36—atherosclerosis	1e-06	1.12e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAV1—atherosclerosis	9.98e-07	1.12e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOA1—atherosclerosis	9.96e-07	1.12e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—atherosclerosis	9.92e-07	1.11e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LPL—atherosclerosis	9.84e-07	1.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—atherosclerosis	9.75e-07	1.1e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—atherosclerosis	9.71e-07	1.09e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—atherosclerosis	9.6e-07	1.08e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARA—atherosclerosis	9.53e-07	1.07e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—atherosclerosis	9.48e-07	1.06e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD36—atherosclerosis	9.35e-07	1.05e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—atherosclerosis	9.33e-07	1.05e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARA—atherosclerosis	9.3e-07	1.04e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AGT—atherosclerosis	9.23e-07	1.04e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—atherosclerosis	9.09e-07	1.02e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—atherosclerosis	9.04e-07	1.02e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AGT—atherosclerosis	9.01e-07	1.01e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAV1—atherosclerosis	8.96e-07	1.01e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOA1—atherosclerosis	8.94e-07	1e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—atherosclerosis	8.87e-07	9.96e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—atherosclerosis	8.86e-07	9.95e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—atherosclerosis	8.83e-07	9.91e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—atherosclerosis	8.77e-07	9.85e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAV1—atherosclerosis	8.74e-07	9.82e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOA1—atherosclerosis	8.72e-07	9.8e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARA—atherosclerosis	8.69e-07	9.76e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—INS—atherosclerosis	8.61e-07	9.67e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—atherosclerosis	8.56e-07	9.61e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AGT—atherosclerosis	8.42e-07	9.45e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—atherosclerosis	8.27e-07	9.29e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—atherosclerosis	8.25e-07	9.26e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—atherosclerosis	8.18e-07	9.19e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAV1—atherosclerosis	8.17e-07	9.18e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—atherosclerosis	8.16e-07	9.17e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—atherosclerosis	8.15e-07	9.16e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—atherosclerosis	8.15e-07	9.16e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOA1—atherosclerosis	8.15e-07	9.15e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.97e-07	8.95e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—atherosclerosis	7.95e-07	8.92e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—atherosclerosis	7.88e-07	8.85e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—INS—atherosclerosis	7.73e-07	8.68e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—atherosclerosis	7.71e-07	8.66e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—atherosclerosis	7.69e-07	8.63e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—atherosclerosis	7.63e-07	8.57e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—atherosclerosis	7.59e-07	8.53e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—atherosclerosis	7.55e-07	8.48e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—INS—atherosclerosis	7.54e-07	8.47e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	7.44e-07	8.36e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—atherosclerosis	7.37e-07	8.27e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—atherosclerosis	7.18e-07	8.07e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—atherosclerosis	7.1e-07	7.97e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—atherosclerosis	7.08e-07	7.95e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—INS—atherosclerosis	7.04e-07	7.91e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—atherosclerosis	6.91e-07	7.76e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—atherosclerosis	6.9e-07	7.75e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—atherosclerosis	6.77e-07	7.61e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—atherosclerosis	6.63e-07	7.44e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—atherosclerosis	6.63e-07	7.44e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—atherosclerosis	6.61e-07	7.43e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—atherosclerosis	6.46e-07	7.25e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—atherosclerosis	6.39e-07	7.18e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—atherosclerosis	6.2e-07	6.96e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—atherosclerosis	6.18e-07	6.94e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—atherosclerosis	6.07e-07	6.82e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—atherosclerosis	6.05e-07	6.79e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.65e-07	6.35e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—atherosclerosis	5.55e-07	6.23e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—atherosclerosis	5.4e-07	6.07e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—atherosclerosis	5.12e-07	5.75e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—atherosclerosis	4.29e-07	4.82e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—atherosclerosis	3.47e-07	3.9e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—atherosclerosis	3.11e-07	3.5e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—atherosclerosis	3.04e-07	3.41e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—atherosclerosis	2.84e-07	3.19e-06	CbGpPWpGaD
